Pharmacomodulations around an anti-Alzheimer drug-candidate
Alzheimer's disease is a complex and multifactorial disease characterized by extracellular Aβ peptide deposits related to the deregulation of APP metabolism, intracellular aggregation of hyper and abnormally phosphorylated isoforms of Tau proteins, cell death and neuroinflammation. Targeting al...
Saved in:
Main Authors: | Sylvain Marc (Author), Christophe Mésangeau (Author), Mathilde Coevoet (Author), Amélie Barczyk (Author), Stéphane Burlet (Author), Philippe Verwaerde (Author), Cecilia Estrella (Author), Cyrille Brantis (Author), Nicolas Sergeant (Author), Pascal Carato (Author), Patricia Melnyk (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oxidized-LDL Deteriorated the Renal Residual Function and Parenchyma in CKD Rat through Upregulating Epithelial Mesenchymal Transition and Extracellular Matrix-Mediated Tubulointerstitial Fibrosis-Pharmacomodulation of Rosuvastatin
by: Pei-Hsun Sung, et al.
Published: (2022) -
Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease
by: Barbara Miziak, et al.
Published: (2021) -
Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease
by: Wen-Yu Wu, et al.
Published: (2017) -
Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels
by: Kohji Fukunaga, et al.
Published: (2019) -
Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
by: Luca Piemontese, et al.
Published: (2018)